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Abstract 
Experimental autoimmune encephalomyelitis (EAE) is an inflammatory demyelinating disease of the 
central nervous system (CNS) and can be induced by inoculation of animals with homogenized CNS 
tissue or highly purified myelin proteins such as myelin basic protein (MBP) or proteolipid protein 
(PLP). It is widely studied as a possible animal model of multiple sclerosis. We performed the present 
neurophysiological study to define the location of nerve conduction abnormalities in EAE induced by 
immunization with PLP (PLP-EAE) and in EAE induced by immunization with MBP (MBP-EAE) in 
the Lewis rat. In rats with tail weakness due to acute PLP-EAE, conduction was normal in the spinal 
nerve roots and peripheral nerves but there was evidence of conduction block in a high proportion of 
the fibres in the dorsal columns of the lumbosacral spinal cord. In contrast, in acute MBP-EAE, there 
was conduction block in a high proportion of fibres in the sacral dorsal and ventral roots of the 
peripheral nervous system (PNS) and in the dorsal columns of the lumbosacral spinal cord. The 
distribution of nerve conduction abnormalities is consistent with previous histological studies showing 
that inflammation and primary demyelination are restricted to the CNS in PLP-EAE, but are present in 
the CNS and in the spinal roots of the PNS in MBP-EAE. The restriction of functional abnormalities 
to the CNS in PLP-EAE but not in MBP-EAE may have implications for the human inflammatory 
demyelinating diseases, including multiple sclerosis. 
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Introduction 
Experimental autoimmune encephalomyelitis (EAE) is an inflammatory demyelinating disease of the 
central nervous system (CNS) induced by the inoculation of susceptible animals, such as Lewis rats, 
with homogenized CNS tissue or highly purified myelin proteins, namely myelin basic protein (MBP) 
or proteolipid protein (PLP), together with complete Freund's adjuvant (CFA). It can also be induced 
by the passive transfer of MBP-specific or PLP-specific T cells. Experimental autoimmune 
encephalomyelitis is widely studied as a possible animal model of multiple sclerosis. 
 
Neurophysiological techniques can be used to assess function in entire CNS and peripheral nervous 
system (PNS) pathways. In locating the site of functional abnormalities in EAE, such studies are 
complementary to histological examination, which generally assesses only small samples of functional 
pathways. In electrophysiological studies of whole spinal cord-induced acute EAE in the rabbit and 
Lewis rat, conduction abnormalities consistent with acute demyelination are present in the proximal 
PNS as well as in the CNS (Pender and Sears, 1982, 1984, 1985, 1986; Pender, 1986a, b, 1988a, 
1989). Similar findings are present in MBP-induced acute EAE (MBP-EAE) (Pender, 1986b, 1988b, 
1989), passively transferred MBP-EAE (Heininger et al., 1989) and in whole spinal cord-induced 
chronic relapsing EAE in the Lewis rat (Stanley and Pender, 1991). 
 
We performed the present study to assess the location of nerve conduction abnormalities in acute 
PLP-EAE and to compare the findings with those in acute MBP-EAE. Because tail weakness is the 
main neurological sign of PLP-EAE in the Lewis rat and is also invariably present in MBP-EAE, the 
electrophysiological studies were carried out on the sacral segments of the CNS and PNS. We found 
that conduction abnormalities were confined to the CNS in PLP-EAE, but were present in both the 
CNS and proximal PNS in MBP-EAE. 
 
 
Material and methods 
 
Animals 
Specific pathogen-free male Lewis rats (JC strain) were obtained from the University of Queensland 
Pinjarra Hills breeding colony and were kept five to a cage with an unrestricted supply of rat cubes 
and water. The experiments, performed in accordance with National Health and Medical Research 
Council of Australia guidelines for animal experimentation, were approved by the local ethics 
committee. 
 
Preparation of proteins 
 
Proteolipid protein 
Proteolipid protein was prepared as previously described (Chalk et al., 1994) using the methods of 
Folch et al. (1957) and Bizzozero et al. (1982). Briefly, 30 g of fresh bovine spinal cord, homogenized 
in a Waring blender with 570 ml of chloroform/methanol (2:1 vol/vol), was filtered and washed three 
times with water/methanol (1:1 vol/vol). Proteolipid protein in the concentrated (X 10), washed bovine 
spinal cord chloroform:methanol extract was precipitated by the addition of cold (4°C) diethyl ether. 
The PLP precipitate was collected by centrifugation, the solutes were discarded, dry nitrogen gas was 
used to remove remaining traces of diethyl ether and the partially dried PLP-containing precipitate was 
redissolved in chloroform/methanol/acetic acid (200:100:1 vol/vol/vol). The remaining lipids were 
separated from the PLP apoprotein by gel permeation chromatography using 
chloroform/methanol/acetic acid (200:100:1 vol/vol/vol) as the solvent and a column of LH-60 
(Pharmacia LKB Biotechnology AB, Uppsala, Sweden) measuring 40 cm X25 mm with a flow rate of 
20 ml/h. The absorbance of the eluate was monitored at 278 nm. The second protein peak from the 
diethyl ether-extracted PLP-containing sample, separated from brain lipids on the column of LH-60, 
was collected and repoured (without further concentration) onto the column of LH-60. The 
subsequently collected PLP apoprotein was converted to a water-soluble form according to the method 
of Sherman and Folch-Pi (1970) by the slow dropwise addition of water while at the same time 
evaporating the chloroform and methanol with dry gaseous nitrogen. The resultant clear solution was 
then dialysed with dialysis tubing of molecular weight cut-off 5 kD (Union Carbide Corporation, 
Chicago, Illinois, USA). The protein concentration was assayed with a Pierce protein assay kit (Pierce, 
Rockford, Illinois, USA). 
 
The purity of the PLP preparation and the possibility of MBP contamination were assessed with 
12.5% sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDSPAGE) (Laemmli, 1970). 
Electroblotting of PLP was performed using the method of Macklin et al. (1982). The primary 
antibody was a rabbit anti-bovine-MBP antibody (Advanced Immunochemical Services Incorporated, 
Longbeach, California, USA, Cat. No. 021222B). The secondary antibody was a peroxidase-
conjugated swine anti-rabbit antibody (Dako A/G, Glostrup, Denmark, Cat. No. P217). 
 
Myelin basic protein 
Myelin basic protein was prepared from guinea-pig spinal cord (after removal of the spinal roots) by 
the method of Deibler et al. (1972). Its purity was assessed by SDS-PAGE (Laemmli, 1970). 
 
 
Induction of EAE 
 
Proteolipid protein-experimental autoimmune encephalomyelitis 
The PLP inoculum was prepared by mixing CFA (H37Ra Difco Laboratories, Detroit, Michigan, 
USA) containing additional killed and dried Mycobacterium tuberculosis (H37RA Difco) (8 mg/ml of 
CFA) with an equal volume of the PLP-containing solution. Under anaesthesia, rats 9-12 weeks old 
were inoculated intradermally in the medial footpad of the right hind foot with 1000 µg of PLP in a 
total volume of 130 µl. 
 
Myelin basic protein-experimental autoimmune encephalomyelitis 
Myelin basic protein in 0.9% saline was emulsified in an equal volume of incomplete Freund's 
adjuvant (Difco) (IFA) containing a suspension of 4 mg of killed and dried M. butyricum (Difco) per 
millilitre of IFA. Rats were inoculated with 100 µl of the MBP-containing emulsion into the medial 
footpad of each hind foot. The total dose of MBP was 50 µg per rat. 
 
 
Clinical assessment 
Rats were assessed for tail, hindlimb and forelimb weakness graded in each region on a scale of 0 (no 
weakness) to 4 (complete paralysis) from day 7 as previously described (Pender, 1986b). The total 
clinical score was obtained by adding these three scores (maximum score = 12). 
 
 
Electrophysiological studies 
 
Preparation of animals 
Anaesthesia was induced by the intraperitoneal (i.p.) injection of ketamine (74 mg/kg) (Mavlab Pty. 
Ltd., Slacks Creek, Australia), xylazine (9 mg/kg) (Parnell Laboratories, Silverwater, Australia) and 
atropine (36 µg/kg) (Apex Laboratories, St Marys, Australia) and maintained with further i.p. 
injections of half of the initial dose when a withdrawal response to pain, elicited in the left hindlimb 
by pinching the hindlimb digits, was present. An adequate depth of anaesthesia was maintained 
without depressing the corneal reflex. The rats breathed spontaneously through a tracheal cannula 
(Intramedic polyethylene tubing No. 7445, Becton Dickinson, New Jersey, USA). The tail was 
wrapped in cotton wool to minimize heat loss from this area. To maintain the temperature of the 
animal at 37°C, a metal box, containing circulating water at 42°C (Thermomix 1441, B. Braun 
Melsungen AG, Germany), was placed under the animal during the laminectomy and during the 
electrophysiological studies. An i.p. injection of 8 ml of compound sodium lactate intravenous 
infusion BP (Hartmann's solution) (Baxter Healthcare Pty Ltd, Old Toongabbie, Australia) was given 
at the beginning of each experiment, and 1 ml of Haemaccel (Behringwerke AG, Marburg, Germany) 
was given i.p. after the laminectomy had been performed, prior to neurophysiological recordings. 
 
Dorsal root entry zone (DREZ) recordings 
A T12-L5 laminectomy was performed, blood loss being minimized with local pressure and gelatin 
sponge (Gelfoam®) (The Upjohn Company, Kalamazoo, Michigan, USA). The rat was mounted on a 
frame and a pool was formed with raised skin flaps and the dura opened. After rinsing of the tissues 
with warmed (37°C) compound sodium lactate solution, warmed (37°C) paraffin oil was added to the 
pool to prevent tissue drying. A thermostatically controlled infrared lamp was used to maintain the 
temperature of the paraffin pool at 37°C. The rectal temperature was usually 36-37°C under these 
conditions. A segment of the left ventral caudal trunk, just distal to its junction with the S2 ventral 
primary ramus, was exposed and stimulated in continuity with two 0.25 mm diameter platinum wire 
electrodes 3 mm apart. The cathode was proximal to the anode. Stimuli were 0.1 ms square-wave 
voltage pulses (Isolated stimulator DS2, Digitimer Ltd, Welwyn Garden City, Hertfordshire, UK) 
delivered at 0.33 Hz with a programmable triggering device (Digitimer 4030, Digitimer Ltd). The 
threshold for tail movement was usually 0.3-0.4 V. During the course of the experiment the threshold 
for tail twitch often rose, probably from ischaemia of the ventral caudal trunk. When the threshold for 
tail twitch increased beyond 0.6 V, or if the corneal reflex became absent, the experiment was ceased. 
 
Volume conductor recordings were made over the left S2 DREZ with a 0.5 mm diameter silver ball 
electrode as the active electrode (Fig. 1). The reference electrode was a platinum wire placed on the 
right paravertebral tissue at the same level as the active electrode. A ground electrode was placed, via 
a steel supporting pin, on the right ilium. The recording electrodes were shielded leads connected to 
field effect transistor source-followers, and thence to a preamplifier bandwidth 5.3-10 kHz) and thence 
to an oscilloscope (Tektronix 5D10 Waveform Digitizer, Tektronix Inc., Beaverton, Oregon, USA) . 
For all recordings, negativity at the active recording electrode resulted in an upward deflection on the 
oscilloscope. Recordings were photographed with an oscilloscope camera. Conduction velocities were 
calculated after (allowing for the utilization time (0.1 ms) (Blair and Erlanger, 1936). Conduction 
distance was measured as the length of a piece of thread placed along the conduction pathway from 
the stimulation site on the ventral caudal trunk to the recording site on the S2 DREZ. 
 
 
 
 
 
Fig. 1 Schematic diagram of the stimulating and recording arrangements for the S2 dorsal root, dorsal root entry 
zone and ventral root recordings and for the compound muscle action potential recording. DRG = dorsal root 
ganglion. S = stimulus. 1: the active recording electrode for the compound muscle action potential; 2: the reference 
recording electrode for the compound muscle action potential; 3: the active recording electrode for the S2 dorsal 
root recording; 4: the active recording electrode for the S2 dorsal root entry zone recording; 5: the active recording 
electrode for the S2 ventral root recording; 6: the reference electrode for the S2 dorsal root, dorsal root entry zone 
and ventral root recordings was placed on the right paravertebral tissue. 
 
S2 dorsal root recordings 
The left S2 dorsal root was identified and gently lifted with a Cawthorne's stapedectomy hook No. 3 
(Downs Surgical Ltd, Mitcham, Surrey, UK) so that a small piece of plastic sheeting measuring 2.5 X6 
mm could be placed underneath the root (Fig. 1). The 0.5 mm diameter silver ball electrode was 
placed on the segment of the S2 dorsal root overlying the plastic sheet (6-10 mm distal to the S2 
DREZ), and the reference electrode was placed on the right paravertebral tissue at the same level as 
the active recording electrode. The ventral caudal trunk was stimulated as for the DREZ recordings. 
 
Dorsal column recordings 
The active electrode was a 0.5 mm diameter silver ball electrode placed on the left dorsal column at 
the level of the S4 DREZ (Fig. 2). The reference electrode was a 0.2 mm diameter platinum wire 
electrode placed on the right paravertebral tissue at the same level as the active recording electrode. 
Two J-shaped 0.25 mm diameter stimulating platinum wire electrodes were placed 3 mm apart on the 
left dorsal column, with the cathode caudal, 0.5 mm from the midline and 17 mm rostral to the active 
recording electrode (Fig. 2). Stimulation was by 0.33 Hz square-wave voltage pulses of 20 µs 
duration. Preliminary studies revealed that cutting all dorsal roots caudal to, and including, the L4 
dorsal root did not alter the duration or amplitude of the dorsal column compound action potential. 
Sectioning of the left dorsal column 4 mm caudal to the stimulating cathode resulted in an -50% 
reduction in the amplitude of the potential and further sectioning of the right dorsal column abolished 
the potential. 
 
 
 
Fig. 2 Schematic diagram of the stimulating and recording arrangements for the dorsal column recordings.  
S = stimulus; 1: the active recording electrode; 2: the reference recording electrode which was placed on the right 
paravertebral tissue. 
 
 
S2 ventral root recordings 
The left ventral caudal trunk was stimulated as described above for the S2 DREZ recordings. The L5, 
L6, sacral and coccygeal dorsal roots were cut and folded back and the caudal spinal cord was rotated 
so that the left sacral and coccygeal ventral roots could be identified. The left and right S3, S4 and 
coccygeal ventral roots were cut and folded back. The left S2 ventral root was lifted gently with the 
Cawthorne's stapedectomy hook No. 3 and a small piece of plastic sheeting was placed beneath its 
proximal portion as described above for the left S2 dorsal root. A 0.5 mm diameter silver ball 
electrode was placed on the segment of the left S2 ventral root lying on the plastic sheeting (12-16 mm 
distal to the S2 ventral root exit zone) (Fig. 1). The reference electrode was placed on the right 
paravertebral tissue at the same level as the active recording electrode. Stimuli were 0.1 ms square-
wave voltage pulses delivered at 0.33 Hz. 
 
M wave recordings 
The ventral caudal trunk was stimulated as described above for the S2 DREZ recordings, except that 
the polarity of the electrodes was reversed so that the cathode was closer than the anode to the 
recording site. Recordings were made of the compound muscle action potential from the left ventral 
muscles of the proximal tail, 1 cm distal to the base of the tail (Fig. 1). The active electrode was a 25 
gauge needle inserted into the tail muscle, and the reference electrode was a similar needle inserted 
into the sacral vertebral column. Stimuli were 0.1 ms square-wave voltage pulses delivered at 0.33 Hz. 
 
 
Histological studies 
At the completion of the neurophysiological studies four rats (three with PLP-EAE and one 
with MBP-EAE) were perfused through the left ventricle of the heart with isotonic saline 
followed by modified Karnovsky's fixative. Specimens were taken from the lumbosacral 
spinal cord, and the tissue was processed for histological examination as described below. 
 
Light microscopy 
The tissue was processed according to the method of Nguyen and Pender (1989). The tissue 
samples were postfixed in osmium tetroxide (Dalton's solution), dehydrated in ascending 
alcohols and embedded in glycol methacrylate (Technovit 7100, Kulzer GmbH, Wehrheim, 
Germany). Sections (1.0 µm) were cut with a Ralph glass knife on a LKB retracting 
microtome and stained with cresyl fast violet. 
Electron microscopy 
Tissue samples were postfixed with osmium tetroxide, stained en bloc with uranyl acetate, 
dehydrated in a series of graded ethanol solutions followed by absolute acetone and embedded 
in epoxy resin. Ultrathin sections were stained with lead citrate and examined with a Jeol 
JEM-1200 EXII electron microscope. 
 
Statistical analysis 
To compare the recordings from normal rats with those from rats with PLP-EAE and MBP-
EAE, one-way analysis of variance (ANOVA) was used when the data were normally 
distributed. Where a significant F result was obtained, further post hoc comparisons were 
performed between groups using a two-tailed t test. To correct the P value for multiple 
comparisons, the Bonferroni method was used. The statistical analysis program used was 
GraphPAD InStat (GraphPAD Software, San Diego California, USA). 
 
 
Results 
 
Normal controls 
Electrophysiological studies were performed on 23 normal Lewis rats aged 9-13 weeks. 
 
Table 1 Maximal compound muscle action potential evoked in the proximal ventral tail muscles by stimulation 
of the ventral caudal trunk 
 
 Normal Controls PLP-EAE MBP-EAE 
 n Range Mean ± SD n Range Mean ± SD n Range Mean ± SD 
F value 
(ANOVA) 
Peak-to-peak 
Amplitude (mV) 
11 3.16-10.16 5.74±2.12 8 4.40-8.88 5.78±1.50 
pc = NS 
10 3.48-7.36 5.21±1.25 
pc = NS 
0.34 
Latency to peak 
of positivity (ms) 
11 2.25-3.34 2.65±0.37 8 2.38-3.32 2.72±0.34 
pc = NS 
10 2.08-3.08 2.60±0.28 
pc = NS 
0.29 
Latency to peak 
of negativity (ms) 
11 3.50-5.02 4.35±0.55 8 3.44-5.50 4.32±0.70 
pc = NS 
10 2.86–5.70 4.50±0.76 
pc = NS 
0.20 
 
ANOVA = one-way analysis of variance; p c = P value calculated in comparison with normal controls using ANOVA with 
Bonferroni correction for multiple comparisons; NS = not significant (P > 0.05). 
 
 
M wave recordings 
The compound muscle action potential in the proximal ventral tail muscles evoked by stimulation of 
the left ventral caudal trunk was examined in 11 normal rats (Table 1). The normal response consists 
of a biphasic wave (positive, negative). 
 
Dorsal root recordings 
Conduction from the left ventral caudal trunk to the proximal S2 dorsal root was studied in 10 normal 
rats (Fig. 3A and Table 2). The normal dorsal root response consists of a biphasic wave (positive, 
negative). The initial positivity is due to passive outward current driven by the approaching impulses, 
and the negativity is due to active inward current occurring during the rising phase of the action 
potential under the active recording electrode. 
 
Dorsal root entry zone recordings 
To assess conduction through the PNS afferent pathway, volume conductor recordings were made of 
the S2 DREZ response evoked by stimulation of the left ventral caudal trunk in 19 normal rats. The 
normal DREZ response consists of the biphasic (positive, negative) afferent volley potential followed 
by the N wave, a field potential due to synaptic currents in second order neurons in the dorsal 
horn excited mainly by low-threshold cutaneous afferents (Fig. 4A and Table 3). 
 
Ventral root recordings 
Conduction from the left ventral caudal trunk to the proximal S2 ventral root was assessed in 
six normal rats (Fig. 5A and Table 4). 
 
Dorsal column recordings 
Conduction in the lumbosacral dorsal columns was assessed in 10 normal rats (Fig. 6A and 
Table 5). The normal response consisted of a biphasic wave (positive, negative). Repetitive 
supramaximal dorsal column stimulation (10 Hz for 60 s) resulted in a mean amplitude 
reduction of 3.8±2.5% (n = 5). 
 
Fig. 3 Volume conductor recordings of the maximal S2 dorsal root compound action potential evoked by 
stimulation of the ventral caudal trunk in a normal rat (A), in a rat with PLP-EAE (B) and in a rat with MBP-
EAE (C). The onset of the stimulus is indicated by a vertical line. 
 
 
Proteolipid protein-experimental autoimmune encephalomyelitis 
 
Clinical findings 
Neurophysiological studies were performed on 11 rats with PLP-EAE, 13-20 days after 
inoculation and 2-4 days after the onset of neurological signs. At the time of the 
neurophysiological studies, the rats had severe tail weakness or tail paralysis. Two rats also 
had hindlimb weakness. The mean total clinical score of rats with PLP-EAE at the time of 
neurophysiological study was 4.2± 1.2. 
 
Table 2 Maximal S2 dorsal root compound action potential evoked by stimulation of the ventral caudal trunk 
 
 Normal Controls PLP-EAE MBP-EAE 
 n Range Mean ± SD n Range Mean ± SD n Range Mean ± SD 
F value 
(ANOVA) 
Peak-to-peak 
Amplitude (µV) 
10 816-2060 1436±385 8 760-1680 1225±298  
pp< 0.01 
8 220-1040 551±315 
pc <0.001 
pp <0.01 
15.90 
Conduction  
velocity of peak 
of negativity 
 (m/s) 
6* 46.6-48.5 47.5±0.7 8 46.7-49.4 48.2±1.0 
pc = NS 
7* 37.4-48.9 41.5±3.9 
pc < 0.05 
pp < 0.01 
17.27 
 
P values calculated by using ANOVA with Bonferroni correction for multiple comparisons;  
pc = compared with normal controls; pp = compared with rats with PLP-EAE; *conduction distance measured in only 
six normal controls and seven rats with MBP-EAE. 
 
 
 
 
M wave recordings 
The compound muscle action potential in proximal ventral tail muscles evoked by stimulation 
of the ventral caudal trunk was normal in rats with PLP-EAE (Table 1). 
 
Dorsal root recordings 
Conduction from the left ventral caudal trunk to the proximal S2 dorsal root was studied in 
eight animals with PLP-EAE. The mean peak-to-peak amplitude and the mean velocity of the 
peak of the negativity of the maximal dorsal root compound action potential were not 
significantly different from the corresponding values in normal controls (Fig. 3 and Table 2). 
Dorsal root entry zone recordings 
In rats with PLP-EAE, the mean peak-to-peak amplitude of the maximal afferent volley 
potential and the mean amplitude of the N wave peak were significantly reduced compared with 
the corresponding values in normal controls (Fig. 4 and Table 3). However, the mean 
conduction velocity of the peak of the negativity of the maximal afferent volley potential and 
the mean latency of the N wave were not significantly different from those in normal controls. 
In view of the normal amplitude of the S2 dorsal root compound action potential recorded 6-10 
mm away, the reduction in the peak-to-peak amplitude of the S2 DREZ afferent volley potential 
without temporal dispersion and the reduction in the N wave amplitude indicate conduction 
block immediately distal to the recording site over the DREZ. 
 
Ventral root recordings 
Conduction from the left ventral caudal trunk to the proximal S2 ventral root was assessed in 
seven rats with PLP-EAE. The mean peak-to-peak amplitude and the mean velocity of the peak 
of the negativity of the maximal ventral root response were not significantly different from the 
corresponding values in normal controls (Fig. 5 and Table 4). 
 
 
 
Fig. 4 Volume conductor recordings of the maximal S2 dorsal root entry zone afferent volley potential and N wave 
evoked by stimulation of the ventral caudal trunk in a normal control rat (A), in a rat with PLP-EAE (B) and in a rat 
with MBP-EAE (C). 
 
Dorsal column recordings 
Conduction in the lumbosacral dorsal columns was assessed in 11 rats with PLP-EAE. There 
was a marked reduction in the mean peak-to-peak amplitude of the maximal compound action 
potential compared with normal controls (Fig. 6 and Table 5). As there was no temporal 
dispersion, this reduction indicates either a failure of excitation at the stimulation site or 
conduction block in a high proportion of the dorsal column fibres. The mean latency to the peak 
of the negativity in rats with PLP-EAE was not significantly different from that in normal 
controls. As demyelinated fibres have an impaired ability to transmit trains of impulses 
(McDonald and Sears, 1970), the effect of repetitive supramaximal dorsal column stimulation 
(10 Hz for 60 s) was assessed in four rats with PLP-EAE. Such stimulation resulted in a mean 
amplitude reduction of 11± 17%, which was not significantly different from that in normal 
controls. However, in two of these rats the reductions were 25 and 26%, respectively (>3  SDs 
beyond the normal mean) indicating rate-dependent conduction block rather than a failure of 
excitation. 
 
Table 3 Maximal S2 dorsal root entry zone response evoked by stimulation of ventral caudal trunk 
 
 Normal Controls PLP-EAE MBP-EAE 
 n Range Mean ± SD n Range Mean ± SD n Range Mean ± SD 
F value 
(ANOVA) 
Peak-to-peak 
amplitude of 
afferent volley 
potential (µV) 
19 600-1040 788±102 9 440-900 620±141 
pc <0.01 
9 240-580 397±138 
pc <0.001 
pp <0.01 
32.25 
Conduction  
velocity of peak 
of negativity of 
afferent volley 
potential (m/s) 
9* 49.1-54.0 51.0±2.2 8* 42.2-55.1 50.0±4.5 
pc = NS 
7* 42.2-49.1 44.0±3.4 
pc < 0.01 
pp < 0.05 
9.06 
Amplitude of  
N wave peak 
(mV) 
18 1.08-2.90 1.84±0.52 8 0.28-1.88 1.01±0.54 
pc < 0.01 
9 0.54-1.46 1.06±0.33 
pc < 0.01 
pp = NS 
12.30 
Latency to peak of 
N wave (ms) 
18 1.79-2.44 2.04±0.17 8 1.85-2.27 2.08±0.15 
pc = NS 
9 2.03-2.48 2.24±0.16 
pc <0.05 
pp = NS 
4.58 
 
P values calculated using ANOVA with Bonferroni correction for multiple comparisons; pc = compared with 
normal controls; 
pp = compared with rats with PLP-EAE; *conduction distance measured in only nine normal controls, eight rats with PLP-
EAE and seven rats with MBP-EAE. 
 
 
Histological studies of the lumbosacral spinal cord in PLP-EAE 
Three rats with PLP-EAE were perfused with fixative after completion of the 
neurophysiological studies. Light microscopic histological examination of the lumbosacral 
dorsal columns in the region showing conduction abnormalities revealed meningeal, 
perivascular and parenchymal mononuclear cell infiltrates and primary demyelination (loss of 
the myelin sheath with axonal preservation), as we have recently reported in a detailed 
histological study of PLP-EAE in the Lewis rat (Chalk et al., 1994). The proximal S2 dorsal 
and ventral roots were also examined histologically in one rat after completion of the 
neurophysiological study and were found to be normal, as we found to be the case throughout 
the PNS in our detailed histological study (Chalk et al., 1994). 
 
Fig. 5 Volume conductor recordings of the maximal S2 ventral root compound action potential evoked by stimulation 
of the ventral caudal trunk in a normal rat (A), in a rat with PLP-EAE (B) and in a rat with MBP-EAE (C). 
 
Myelin basic protein-experimental autoimmune encephalomyelitis  
 
Clinical findings 
Neurophysiological studies were performed on 14 rats with MBP-EAE, 12-15 days after inoculation 
and 2-5 days after the onset of neurological signs. At the time of the neurophysiological studies 13 rats 
had tail paralysis and one had severe tail weakness. Eleven rats also had hindlimb weakness. The mean 
total clinical score of rats with MBP-EAE at the time of neurophysiological study was 5.9±1.6 which 
is greater than that in rats with PLP-EAE (P = 0.007). 
 
M wave recordings 
The compound muscle action potential in proximal ventral tail muscles evoked by stimulation of the 
ventral caudal trunk was normal in rats with MBP-EAE (Table 1). 
 
Table 4 Maximal S2 ventral root compound action potential evoked by stimulation of the ventral caudal trunk 
 
 Normal Controls PLP-EAE MBP-EAE 
 n Range Mean ± SD n Range Mean ± SD n Range Mean ± SD 
F value 
(ANOVA) 
Peak-to-peak 
amplitude (µV) 
6 1184-2300 1604±399 7 1060-2480 1604±582 
pc = NS 
9 110-1130 534±351 
pc <0.01 
pp <0.01 
15.16 
Conduction  
velocity of peak 
of negativity 
(m/s) 
6 46.0-51.6 47.6±2.1 7 44.2-51.4 48.1±2.3 
pc = NS 
7* 20.4-48.9 39.3±9.3 
pc = NS 
pp < 0.05 
4.97 
 
P values calculated using ANOVA with Bonferroni correction for multiple comparisons; pc = compared with normal 
controls; pp = compared with rats with PLP-EAE; *conduction distance measured in only seven rats. 
 
Dorsal root recordings 
Conduction from the left ventral caudal trunk to the proximal S2 dorsal root was studied in eight 
animals with MBP-EAE. There was a marked reduction in the mean peak-to-peak amplitude of 
the maximal dorsal root compound action potential compared with normal controls and rats with 
PLP-EAE (Fig. 3 and Table 2). The mean conduction velocity of the peak of the negativity in 
animals with MBP-EAE was also significantly less than that in normal controls and that in rats 
with PLP-EAE. As there was no temporal dispersion, the reduction in the amplitude of the dorsal 
root response in MBP-EAE indicates a failure of excitation at the stimulation site or conduction 
block in a high proportion of the afferent fibres between the ventral caudal trunk and the 
proximal dorsal root. The reduction in the conduction velocity indicates conduction block or 
slowing in the fastest fibres. 
 
Dorsal root entry zone recordings 
Conduction from the ventral caudal trunk to the S2 DREZ was studied in nine animals with 
MBP-EAE. The mean peak-to-peak amplitude and the mean velocity of the peak of the 
negativity of the maximal afferent volley potential were significantly reduced compared with 
the corresponding values in normal controls and in rats with PLP-EAE (Fig. 4 and Table 3). The 
peak of the N wave was significantly decreased in amplitude and prolonged in latency in rats 
with MBP-EAE compared with normal controls but not compared with rats with PLP-EAE. These 
abnormalities in the DREZ recordings in MBP-EAE are mainly explained by the conduction 
abnormalities in the peripheral afferent pathway detected in the S2 dorsal root recordings (see 
above), but conduction abnormalities between the dorsal root and DREZ recording sites may 
also have contributed. 
 
Ventral root recordings 
Conduction from the left ventral caudal trunk to the proximal S2 ventral root was assessed in 
nine rats with MBP-EAE. The mean peak-to-peak amplitude of the maximal response was 
markedly reduced compared with that in normal controls and that in rats with PLP-EAE, 
indicating a failure of excitation at the stimulation site or conduction block in a high proportion 
of the efferent fibres between the ventral caudal trunk and the proximal ventral root (Fig. 5 and 
Table 4). The mean conduction velocity of the peak of the negativity was less than that in 
normal controls and that in rats with PLP-EAE, although the difference from normal controls 
was not statistically significant. However, in four rats with MBP-EAE the velocity was >3 SDs 
below the mean in normal controls, indicating conduction block or slowing in the fastest fibres. 
 
Dorsal column recordings 
Conduction in the lumbosacral dorsal columns was assessed in 11 rats with MBP-EAE. The mean 
peak-to-peak amplitude of the dorsal column compound action potential was markedly reduced 
compared with that in normal controls but was not significantly different from that in rats with 
PLP-EAE (Fig. 6 and Table 5). The latency to the peak of the negativity was increased in MBP-EAE 
compared with that in PLP-EAE and that in normal controls, although the latter difference was not 
statistically significant. As there was no temporal dispersion, the reduction in amplitude indicates a 
failure of excitation at the stimulation site or conduction block in a high proportion of the dorsal 
column fibres in MBP-EAE. The effects of repetitive supramaximal dorsal column stimulation (10 Hz 
for 60 s) were assessed in four rats with MBP-EAE. Such stimulation resulted in a mean amplitude 
increase of 0.7±6%, which was not significantly different from the effect in normal controls. 
 
 
 
Fig. 6 Volume conductor recordings of the maximal sacral dorsal column compound action potential evoked by 
stimulation of the lumbar dorsal column in a normal rat (A), in a rat with PLP-EAE (B) and in a rat with MBP-EAE (C). 
 
Table 5 Maximal lumbosacral dorsal column compound action potential 
 
 Normal Controls PLP-EAE MBP-EAE 
 n Range Mean ± SD n Range Mean ± SD n Range Mean ± SD 
F value 
(ANOVA) 
Peak-to-peak 
amplitude (µV) 
10 154-316 228±55 11 0-308 92±91 
pc < 0.01 
11 0-240 71±71 
pc <0.001 
pp = NS 
13.55 
Latency to peak  
of negativity (µs) 
10 390-440 411±21 9* 380-445 403±22 
pc = NS 
7† 390-480 441±35 
pc = NS 
pp < 0.05 
4.65 
 
P values calculated using ANOVA with Bonferroni correction for multiple comparisons; pc = compared with normal controls; pp = 
compared with rats with PLP-EAE; *response absent in two rats; †response absent in four rats. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7 Electron micrograph of a longitudinal section through the dorsal column of the S2-3 spinal cord of a rat with MBP-
EAE that had been studied neurophysiologically and found to have evidence of dorsal column conduction block. 
Demyelinated axons (arrows) can be seen. Bar = 2 µm. 
 
Histological studies of the lumbosacral spinal cord in MBP-EAE 
Light microscopic histological examination of the lumbosacral spinal cord from one rat with MBP-
EAE that was perfused with fixative at the completion of the neurophysiological studies revealed 
meningeal, subpial and perivascular infiltrates of mononuclear cells and some primary demyelination 
in the dorsal columns in the region showing conduction abnormalities. There was little demyelination 
in transverse sections but more prominent demyelination in longitudinal sections. Electron microscopy 
confirmed the presence of primary demyelination (Fig. 7). 
 
 
Discussion 
In this study we found that conduction abnormalities were restricted to the CNS in acute PLP-EAE, 
but were present in the CNS and proximal PNS in acute MBP-EAE. In the CNS there was a marked 
reduction in the peak-to-peak amplitude, without temporal dispersion, of the dorsal column compound 
action potential in PLP-EAE and MBP-EAE. This could be due to a failure of excitation at the 
stimulation site caused by axonal degeneration or due to conduction block caused by demyelination. 
Further reduction of the amplitude by repetitive supramaximal stimulation in two rats with PLP-EAE 
indicated that demyelination-induced conduction block rather than axonal degeneration was 
responsible for the conduction abnormalities. Moreover, the finding of conduction slowing in the 
dorsal columns at 1-2 weeks and restoration of conduction at 4 weeks after clinical recovery from 
MBP-EAE (J. B. Chalk, P. A. McCombe and M. P. Pender, unpublished data) also indicates that 
demyelination is responsible for the conduction abnormalities. This conclusion is supported by the fact 
that primary demyelination is the main neuropathological finding in the spinal cord in these forms of 
EAE, whereas axonal degeneration is an infrequent finding (Pender, 1988b, 1989; Chalk et al., 1994). 
In transverse sections of the spinal cord, primary demyelination can be readily identified in PLP-EAE 
but is mainly limited to the CNS parts of the ventral root exit and dorsal root entry zones in MBP-
EAE. However, in the present study, longitudinal sections revealed significant primary demyelination 
in the dorsal columns of the spinal cord in a rat with dorsal column conduction abnormalities due to 
MBP-EAE (Fig. 7). In addition to demyelination, structurally minor yet functionally significant 
changes in the myelin sheath, such as disruption of the paranodal axoglial junctions (Hirano and 
Dembitzer 1978), may also contribute to the CNS conduction block in MBP-EAE. 
 
In PLP-EAE, in contrast to the severe conduction abnormalities in the CNS, there was normal 
conduction through the PNS, namely the sacral dorsal and ventral roots and the peripheral nerve. The 
abnormalities in the DREZ recordings in PLP-EAE can be accounted for by conduction block in the 
oligodendrocyte-myelinated portion of the DREZ that extends into the proximal dorsal root (the central 
tissue projection). The neurological sign of tail weakness in rats with PLP-EAE is most likely due to 
demyelination-induced conduction block at the oligodendrocyte-myelinated region of the ventral root 
exit zone. This region is a site of predilection for primary demyelination in PLP-EAE (Chalk et al., 
1994) and is also a major site of demyelination and conduction block causing weakness in whole 
spinal cord-induced EAE (Pender, 1986a, 1988a). Our finding that nerve conduction abnormalities are 
restricted to the CNS in PLPEAE is consistent with the results of histological studies showing 
restriction of inflammation and demyelination to the CNS in PLP-EAE (Yamamura et al., 1986; Chalk 
et al., 1994). In other species, such as the rabbit (Williams et al., 1982; Cambi et al., 1983), guinea-
pig (Yoshimura et al., 1985) and mouse (Satoh et al., 1987; Trotter et al., 1987; Tuohy et al., 1988; 
van der Veen et al., 1989) limited histological studies of the PNS have been normal in PLP-EAE. The 
electrophysiological and histological findings are also consistent with biochemical studies showing 
restriction of PLP to the CNS (Lees and Macklin, 1988). 
 
In MBP-EAE, in contrast to PLP-EAE, there were major conduction abnormalities in the proximal 
PNS. The involvement of the PNS in MBP-EAE but not in PLP-EAE cannot be explained by the 
generally more severe clinical involvement in MBP-EAE, as the PNS was spared in rats with severe 
clinical disease (tail paralysis and hindlimb weakness) due to PLP-EAE but not in rats with milder 
clinical disease (tail paralysis without hindlimb weakness) due to MBP-EAE. The reduced amplitude, 
without temporal dispersion, of the sacral ventral root compound action potential in the presence of a 
normal compound muscle action potential elicited by stimulation of the ventral caudal trunk at the 
same site indicates that conduction block is present in the sacral ventral roots in MBP-EAE. It is 
highly likely that the reduced amplitude of the sacral dorsal root response is also due to conduction 
block. Conduction block in the dorsal and ventral routs in MBP-EAE is readily explained by the 
primary demyelination in these roots (Pender, 1986b, 1987, 1988b,c; Chalk et al., 1994). This 
conclusion is supported by the complete restoration of conduction in the sacral ventral and dorsal 
roots at the time of PNS remyelination and clinical recovery (J. B. Chalk, P. A. McCombe and M. P. 
Pender, unpublished data). Conduction in the peripheral nerve itself (from the ventral caudal trunk to 
the tail muscles) was normal in MBP-EAE, as we have previously shown in the sciatic nerve (Pender, 
1988b). In contrast to PLP-EAE, the neurological signs of MBP-EAE can be explained mainly by 
demyelination-induced conduction block in the spinal roots in the PNS, as we have previously 
reported (Pender, 1988b,c; Pender et al., 1989). The involvement of the PNS in MBP-EAE is 
explained by the presence of MBP in the PNS (Brostoff and Eylar, 1972; Greenfield et al., 1973). 
 
Our findings of restriction of functional abnormalities to the CNS in PLP-EAE, but not in MBP-
EAE, may have implications for the human inflammatory demyelinating diseases, including multiple 
sclerosis. Abnormal auto-reactivity to PLP and MBP has been incriminated in multiple sclerosis. 
Multiple sclerosis is classically regarded as a disease restricted to the CNS, although the PNS may be 
involved in at least some cases (Waxman, 1993). Restriction of autoimmune demyelination to the CNS 
in multiple sclerosis would suggest that PLP, or another antigen confined to the CNS such as 
myelin/oligodendrocyte glycoprotein (Gardinier et al., 1992), is the target antigen. Involvement of the 
PNS as well as the CNS in multiple sclerosis might occur when the immune attack is directed at MBP 
or other antigens, such as galactocerebroside, which are present in both CNS and PNS myelin. 
Interestingly, PNS disease and antibodies to MBP occur in some individuals immunized with rabies 
vaccine containing CNS tissue (Hemachudha et al., 1987, 1988). 
 
In conclusion, we have shown that nerve conduction abnormalities are restricted to the CNS in PLP-
EAE but not in MBP-EAE in the Lewis rat. These findings may have implications for multiple 
sclerosis and other human inflammatory demyelinating diseases. 
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